[Commentary to the article: Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43]

Kardiol Pol. 2007 Feb;65(2):214-6; discussion 216-7.
[Article in Polish]
No abstract available